138 related articles for article (PubMed ID: 37005094)
1. Uptake, experiences and barriers to cervical screening for trans and non-binary people in Aotearoa New Zealand.
Carroll R; Tan KKH; Ker A; Byrne JL; Veale JF
Aust N Z J Obstet Gynaecol; 2023 Jun; 63(3):448-453. PubMed ID: 37005094
[TBL] [Abstract][Full Text] [Related]
2. Attitudes of transgender men and non-binary people to cervical screening: a cross-sectional mixed-methods study in the UK.
Berner AM; Connolly DJ; Pinnell I; Wolton A; MacNaughton A; Challen C; Nambiar K; Bayliss J; Barrett J; Richards C
Br J Gen Pract; 2021 Aug; 71(709):e614-e625. PubMed ID: 34001539
[TBL] [Abstract][Full Text] [Related]
3. Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests.
McDowell M; Pardee DJ; Peitzmeier S; Reisner SL; Agénor M; Alizaga N; Bernstein I; Potter J
LGBT Health; 2017 Aug; 4(4):252-259. PubMed ID: 28665783
[TBL] [Abstract][Full Text] [Related]
4. Barriers and facilitators to cervical cancer screening among transgender men and non-binary people with a cervix: A systematic narrative review.
Connolly D; Hughes X; Berner A
Prev Med; 2020 Jun; 135():106071. PubMed ID: 32243938
[TBL] [Abstract][Full Text] [Related]
5. "I teach them. I have no choice": experiences of primary care among transgender people in Aotearoa New Zealand.
Tan KKH; Carroll R; Treharne GJ; Byrne JL; Veale JF
N Z Med J; 2022 Aug; 135(1559):59-72. PubMed ID: 35999782
[TBL] [Abstract][Full Text] [Related]
6. PrEP awareness and protective barrier negotiation among transgender people attracted to men in Aotearoa New Zealand.
Byrne JL; Tan KKH; Saxton PJ; Bentham RM; Veale JF
J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25980. PubMed ID: 36225159
[TBL] [Abstract][Full Text] [Related]
7. Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients.
Reisner SL; Deutsch MB; Peitzmeier SM; White Hughto JM; Cavanaugh TP; Pardee DJ; McLean SA; Panther LA; Gelman M; Mimiaga MJ; Potter JE
PLoS One; 2018; 13(3):e0190172. PubMed ID: 29538411
[TBL] [Abstract][Full Text] [Related]
8. Perceptions of Transgender and Nonbinary Persons Toward Breast and Cervical Cancer Development, Screening, and Potential Impact on Gender-Affirming Hormone Therapy.
Roznovjak D; Petroll AE; Lakatos AEB; Narayan R; Cortina CS
JCO Oncol Pract; 2023 May; 19(5):e794-e800. PubMed ID: 36800556
[TBL] [Abstract][Full Text] [Related]
9. Perspectives and Experiences of Transgender and Non-binary Individuals on Seeking Urological Care.
Chung PH; Spigner S; Swaminathan V; Teplitsky S; Frasso R
Urology; 2021 Feb; 148():47-52. PubMed ID: 33129873
[TBL] [Abstract][Full Text] [Related]
10. Quantitative and mixed analyses to identify factors that affect cervical cancer screening uptake among lesbian and bisexual women and transgender men.
Johnson MJ; Mueller M; Eliason MJ; Stuart G; Nemeth LS
J Clin Nurs; 2016 Dec; 25(23-24):3628-3642. PubMed ID: 27240268
[TBL] [Abstract][Full Text] [Related]
11. Gender Identity and Non-Binary Presentations in Adolescents Attending Two Specialized Services in Italy.
Mirabella M; Piras I; Fortunato A; Fisher AD; Lingiardi V; Mosconi M; Ristori J; Speranza AM; Giovanardi G
J Sex Med; 2022 Jun; 19(6):1035-1048. PubMed ID: 35370103
[TBL] [Abstract][Full Text] [Related]
12. A Single-Center Study of Adherence to Breast Cancer Screening Mammography Guidelines by Transgender and Non-Binary Patients.
Luehmann N; Ascha M; Chwa E; Hackenberger P; Termanini K; Benning C; Sama D; Felt D; Beach LB; Gupta D; Kulkarni SA; Jordan SW
Ann Surg Oncol; 2022 Mar; 29(3):1707-1717. PubMed ID: 34704183
[TBL] [Abstract][Full Text] [Related]
13. Barriers to Possessing Gender-Concordant Identity Documents are Associated with Transgender and Nonbinary People's Mental Health in Aotearoa/New Zealand.
Tan KKH; Watson RJ; Byrne JL; Veale JF
LGBT Health; 2022; 9(6):401-410. PubMed ID: 35605017
[No Abstract] [Full Text] [Related]
14. Cervical Cancer Screening with Human Papillomavirus Self-Sampling Among Transgender Men in El Salvador.
Maza M; Meléndez M; Herrera A; Hernández X; Rodríguez B; Soler M; Alfaro K; Masch R; Conzuelo-Rodríguez G; Obedin-Maliver J; Cremer M
LGBT Health; 2020; 7(4):174-181. PubMed ID: 32407149
[No Abstract] [Full Text] [Related]
15. Human Papillomavirus (HPV) Self-Sampling among Never-and Under-Screened Indigenous Māori, Pacific and Asian Women in Aotearoa New Zealand: A Feasibility Study.
Bromhead C; Wihongi H; Sherman SM; Crengle S; Grant J; Martin G; Maxwell A; McPherson G; Puloka '; Reid S; Scott N; Bartholomew K
Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639352
[TBL] [Abstract][Full Text] [Related]
16. Te Ara Waiora-Implementing human papillomavirus (HPV) primary testing to prevent cervical cancer in Aotearoa New Zealand: A protocol for a non-inferiority trial.
Gibson-Helm M; Slater T; MacDonald EJ; Stevenson K; Adcock A; Geller S; Parag V; Lambert C; Bennett M; Hibma M; Sykes P; Saville M; Hawkes D; Stanton JA; Clueard MA; Jelley G; Lawton B
PLoS One; 2023; 18(3):e0280643. PubMed ID: 36952546
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and minority-stress correlates of past 12-month prescription drug misuse in a national sample of transgender and gender nonbinary adults: Results from the U.S. Transgender Survey.
Kidd JD; Goetz TG; Shea EA; Bockting WO
Drug Alcohol Depend; 2021 Feb; 219():108474. PubMed ID: 33360852
[TBL] [Abstract][Full Text] [Related]
18. Cervical cancer prevention in transgender men: a review.
Weyers S; Garland SM; Cruickshank M; Kyrgiou M; Arbyn M
BJOG; 2021 Apr; 128(5):822-826. PubMed ID: 32931650
[TBL] [Abstract][Full Text] [Related]
19. Improving Cervical Screening in Trans and Gender-Diverse People.
Kerr L; Fisher CM; Jones T
Cancer Nurs; 2022 Jan-Feb 01; 45(1):37-42. PubMed ID: 32976182
[TBL] [Abstract][Full Text] [Related]
20. Are women-who-have-sex-with-women an 'at-risk' group for cervical cancer? An exploratory study of women in Aotearoa New Zealand.
Ellis SJ
Sex Health; 2024 Feb; 21(1):NULL. PubMed ID: 38043923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
